Log in to save to my catalogue

Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofreque...

Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofreque...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_865186051

Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone

About this item

Full title

Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone

Publisher

New York: Springer-Verlag

Journal title

Annals of surgical oncology, 2011-06, Vol.18 (6), p.1624-1629

Language

English

Formats

Publication information

Publisher

New York: Springer-Verlag

More information

Scope and Contents

Contents

Purpose
This study was designed to retrospectively compare the effectiveness of combined transarterial chemoembolization (TACE) plus radiofrequency ablation (RFA) with that of RFA alone in patients with medium-sized (3.1–5.0 cm) hepatocellular carcinoma (HCC).
Methods
From March 2000 to April 2010, 57 patients, each with a single medium-si...

Alternative Titles

Full title

Medium-Sized (3.1–5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_865186051

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_865186051

Other Identifiers

ISSN

1068-9265

E-ISSN

1534-4681

DOI

10.1245/s10434-011-1673-8

How to access this item